Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Theravance Biopharma (TBPH) Shares Repurchased (2022 - 2024)

Theravance Biopharma (TBPH) has disclosed Shares Repurchased for 3 consecutive years, with $445000.0 as the latest value for Q1 2024.

  • Quarterly Shares Repurchased fell 99.2% to $445000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $445000.0 through Dec 2024, down 99.77% year-over-year, with the annual reading at $445000.0 for FY2024, 99.77% down from the prior year.
  • Shares Repurchased for Q1 2024 was $445000.0 at Theravance Biopharma, down from $30.3 million in the prior quarter.
  • The five-year high for Shares Repurchased was $80.5 million in Q2 2023, with the low at $445000.0 in Q1 2024.
  • Average Shares Repurchased over 3 years is $38.7 million, with a median of $32.8 million recorded in 2022.
  • The sharpest move saw Shares Repurchased fell 13.02% in 2023, then tumbled 99.2% in 2024.
  • Over 3 years, Shares Repurchased stood at $34.8 million in 2022, then dropped by 13.02% to $30.3 million in 2023, then tumbled by 98.53% to $445000.0 in 2024.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $445000.0, $30.3 million, and $30.9 million for Q1 2024, Q4 2023, and Q3 2023 respectively.